Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.

OBJECTIVE To determine whether the envelope V3 region from HIV-1 subtypes A, C or D had the same probability of being present in intersubtype recombinant genomes. MATERIALS AND METHODS The envelope C2-C5 and the gag p24-p7 regions from one hundred infants infected perinatally in Tanzania were compared using phylogenetic and recombination analysis. Exact binomial and Fisher's exact tests were used to assess if various genomic regions were more likely to be overrepresented in intersubtype recombinants. RESULTS Of one hundred HIV-1 positive infants analyzed, twenty-two (22%) showed exclusively subtype A sequence in gag and env. Subtype C accounted for twenty-two infants (22%) whereas nineteen infants (19%) were infected by HIV-1 subtype D. Intersubtype recombinant genomes accounted for thirty-seven infections (37%). The V3 region from subtype A was found in all fifteen A-D recombinants (P = 0.00003) and the V3 region from subtype C was found in all twelve C-D recombinants (P = 0.0002). Conversely, subtype D gag sequences were preferentially represented in the gag of A-D recombinants (P = 0.0003) as well as C-D recombinants (P = 0.002). In A-D recombinants, the V3 region of subtype A was generally surrounded by subtype A C3-C5 sequences. In contrast, the V3 region from subtype C was surrounded by subtype D C3-C5 sequences in C-D recombinants. Significant differences were not found in the number of subtype A or subtype C sequences in A-C recombinants. CONCLUSION We have shown that several recombinant HIV-1 viruses have been generated and efficiently transmitted to infants in Tanzania. The recombination patterns showed that the V3 region of subtypes A or C was always selected in A-D and C-D recombinants. This selection suggests that the fitness of subtype D-V3 in perinatal transmission may be reduced with respect to V3 from subtype A and/or subtype C. The elevated number of recombinants transmitted perinatally suggests that co-infection or super-infection by two HIV-1 subtypes is not uncommon in this population.

[1]  E. Halapi,et al.  Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[3]  P. Sharp,et al.  Recombination in HIV-1 , 1995, Nature.

[4]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[5]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[6]  J. Albert,et al.  Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection , 1987, Journal of medical virology.

[7]  C. Giaquinto,et al.  Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Korber,et al.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences , 1994, Journal of virology.

[9]  C. Kuiken,et al.  Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. , 1993, The Journal of general virology.

[10]  E. Holmes,et al.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.

[11]  M. Essex,et al.  Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women , 1994, The Lancet.

[12]  C. Chappey,et al.  Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission , 1995, Journal of virology.

[13]  C. Giaquinto,et al.  Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-To-Child Transmission of HIV. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  B. Chesebro,et al.  Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop , 1997, Journal of virology.

[15]  R. F. Smith,et al.  Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1 , 1994, Journal of virology.

[16]  B. Chesebro,et al.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.

[17]  N. Luo,et al.  Perinatal transmission of HIV-I in Zambia. , 1989, BMJ.

[18]  S. Spector,et al.  Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. , 1994, The Journal of infectious diseases.

[19]  W. Fawzi,et al.  Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. , 1998, AIDS research and human retroviruses.

[20]  J. Nkengasong,et al.  The puzzle of HIV‐1 subtypes in Africa , 1997, AIDS.

[21]  B. Korber,et al.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.

[22]  Donna Spiegelman,et al.  Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania , 1998, The Lancet.

[23]  D. Burke,et al.  Phylogenetic analysis of gag genes from 70 international HIV‐1 isolates provides evidence for multiple genotypes , 1993, AIDS.

[24]  J. Goedert,et al.  High risk of HIV-1 infection for first-born twins , 1991, The Lancet.

[25]  Groen,et al.  Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin , 1995, Journal of virology.

[26]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[27]  A. Halpern,et al.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. , 1995, AIDS research and human retroviruses.

[28]  C. Giaquinto,et al.  Perinatal infection by human immunodeficiency virus type 1 (HIV–1): Relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome , 1991, Journal of medical virology.

[29]  C. Griscelli,et al.  A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. , 1989 .

[30]  W. Fawzi,et al.  Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. , 1999, Virology.

[31]  C. Kuiken,et al.  Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child , 1995, Journal of virology.

[32]  R. Collman,et al.  Determinants of Entry Cofactor Utilization and Tropism in a Dualtropic Human Immunodeficiency Virus Type 1 Primary Isolate , 1998, Journal of Virology.

[33]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[34]  J. Albert,et al.  Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. , 1998, Virology.

[35]  M. Essex,et al.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. , 1998, Proceedings of the National Academy of Sciences of the United States of America.